These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 17669363

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W, Wang X, Wong J, Hedrick CC, Wong H, Castellani LW, Lusis AJ.
    Biochem Biophys Res Commun; 2004 Apr 23; 317(1):223-9. PubMed ID: 15047172
    [Abstract] [Full Text] [Related]

  • 3. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
    Tsukamoto K, Tangirala RK, Chun S, Usher D, Puré E, Rader DJ.
    Mol Ther; 2000 Feb 23; 1(2):189-94. PubMed ID: 10933930
    [Abstract] [Full Text] [Related]

  • 4. Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.
    Yoshikawa T, Shimano H, Chen Z, Ishibashi S, Yamada N.
    Horm Metab Res; 2001 Aug 23; 33(8):472-9. PubMed ID: 11544561
    [Abstract] [Full Text] [Related]

  • 5. Expression of human OSBP-related protein 1L in macrophages enhances atherosclerotic lesion development in LDL receptor-deficient mice.
    Yan D, Jauhiainen M, Hildebrand RB, Willems van Dijk K, Van Berkel TJ, Ehnholm C, Van Eck M, Olkkonen VM.
    Arterioscler Thromb Vasc Biol; 2007 Jul 23; 27(7):1618-24. PubMed ID: 17478758
    [Abstract] [Full Text] [Related]

  • 6. Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Jawien J, Csanyi G, Gajda M, Mateuszuk L, Lomnicka M, Korbut R, Chlopicki S.
    Eur J Pharmacol; 2007 Feb 05; 556(1-3):129-35. PubMed ID: 17174298
    [Abstract] [Full Text] [Related]

  • 7. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
    Yang J, Sato K, Aprahamian T, Brown NJ, Hutcheson J, Bialik A, Perlman H, Walsh K.
    Arterioscler Thromb Vasc Biol; 2004 Aug 05; 24(8):1466-73. PubMed ID: 15178561
    [Abstract] [Full Text] [Related]

  • 8. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD, Coenen KR, Plummer MR, Gruen ML, Hasty AH.
    Am J Physiol Endocrinol Metab; 2008 Feb 05; 294(2):E284-90. PubMed ID: 18029445
    [Abstract] [Full Text] [Related]

  • 9. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
    Valenta DT, Ogier N, Bradshaw G, Black AS, Bonnet DJ, Lagrost L, Curtiss LK, Desrumaux CM.
    Arterioscler Thromb Vasc Biol; 2006 Jul 05; 26(7):1572-8. PubMed ID: 16675720
    [Abstract] [Full Text] [Related]

  • 10. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.
    Liu R, Hojjati MR, Devlin CM, Hansen IH, Jiang XC.
    Arterioscler Thromb Vasc Biol; 2007 Jan 05; 27(1):190-6. PubMed ID: 17038631
    [Abstract] [Full Text] [Related]

  • 11. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P, Pospisilova N, Jamborova G, Pospechova K, Solichova D, Andrys C, Zdansky P, Micuda S, Semecky V.
    Life Sci; 2008 Mar 26; 82(13-14):708-17. PubMed ID: 18289605
    [Abstract] [Full Text] [Related]

  • 12. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
    Schneider JG, Zhu Y, Coleman T, Semenkovich CF.
    Arterioscler Thromb Vasc Biol; 2007 Dec 26; 27(12):2699-706. PubMed ID: 17951320
    [Abstract] [Full Text] [Related]

  • 13. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
    O'Brien KD, McDonald TO, Kunjathoor V, Eng K, Knopp EA, Lewis K, Lopez R, Kirk EA, Chait A, Wight TN, deBeer FC, LeBoeuf RC.
    Arterioscler Thromb Vasc Biol; 2005 Apr 26; 25(4):785-90. PubMed ID: 15692094
    [Abstract] [Full Text] [Related]

  • 14. Atherogenic and pulmonary responses of ApoE- and LDL receptor-deficient mice to sidestream cigarette smoke.
    Han SG, Howatt DA, Daugherty A, Gairola CG.
    Toxicology; 2012 Sep 28; 299(2-3):133-8. PubMed ID: 22659316
    [Abstract] [Full Text] [Related]

  • 15. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages.
    Cullen P, Cignarella A, Brennhausen B, Mohr S, Assmann G, von Eckardstein A.
    J Clin Invest; 1998 Apr 15; 101(8):1670-7. PubMed ID: 9541497
    [Abstract] [Full Text] [Related]

  • 16. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice.
    Huo Y, Zhao L, Hyman MC, Shashkin P, Harry BL, Burcin T, Forlow SB, Stark MA, Smith DF, Clarke S, Srinivasan S, Hedrick CC, Praticò D, Witztum JL, Nadler JL, Funk CD, Ley K.
    Circulation; 2004 Oct 05; 110(14):2024-31. PubMed ID: 15451785
    [Abstract] [Full Text] [Related]

  • 17. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage.
    Li K, Yao W, Zheng X, Liao K.
    Cell Res; 2009 Aug 05; 19(8):1006-17. PubMed ID: 19546885
    [Abstract] [Full Text] [Related]

  • 18. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR, Ishiguro H, Ding L, Yancey PG, Dove DE, Kovacs WJ, Semenkovich CF, Fazio S, Linton MF.
    Circulation; 2007 Sep 18; 116(12):1404-12. PubMed ID: 17724261
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis.
    Merched AJ, Chan L.
    Circulation; 2004 Dec 21; 110(25):3830-41. PubMed ID: 15596565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.